| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1425268
[patent_doc_number] => 06503894
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-07
[patent_title] => 'Pharmaceutical composition and method for treating hypogonadism'
[patent_app_type] => B1
[patent_app_number] => 09/651777
[patent_app_country] => US
[patent_app_date] => 2000-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 54
[patent_no_of_words] => 24407
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/503/06503894.pdf
[firstpage_image] =>[orig_patent_app_number] => 09651777
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/651777 | Pharmaceutical composition and method for treating hypogonadism | Aug 29, 2000 | Issued |
| 09/651250 | Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents, and anti-tumor agents | Aug 29, 2000 | Abandoned |
Array
(
[id] => 731517
[patent_doc_number] => 07037511
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-02
[patent_title] => 'Hydrous cosmetic or pharmaceutical sticks'
[patent_app_type] => utility
[patent_app_number] => 09/640822
[patent_app_country] => US
[patent_app_date] => 2000-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12162
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/037/07037511.pdf
[firstpage_image] =>[orig_patent_app_number] => 09640822
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/640822 | Hydrous cosmetic or pharmaceutical sticks | Aug 16, 2000 | Issued |
Array
(
[id] => 1202888
[patent_doc_number] => 06720340
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-13
[patent_title] => 'Nicotine receptor agonists in stem cell and progenitor cell recruitment'
[patent_app_type] => B1
[patent_app_number] => 09/627643
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11712
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/720/06720340.pdf
[firstpage_image] =>[orig_patent_app_number] => 09627643
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/627643 | Nicotine receptor agonists in stem cell and progenitor cell recruitment | Jul 27, 2000 | Issued |
| 09/555172 | REDUCING BLOOD CHOLESTEROL BY IN VIVO PRECIPITATION OF BILE CONSTITUENTS WITH GROUP II OR -III METAL SUBSTANCES | Jul 17, 2000 | Abandoned |
Array
(
[id] => 1369908
[patent_doc_number] => 06566398
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Method for treatment of external secretion disorders'
[patent_app_type] => B1
[patent_app_number] => 09/615703
[patent_app_country] => US
[patent_app_date] => 2000-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9010
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 288
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566398.pdf
[firstpage_image] =>[orig_patent_app_number] => 09615703
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/615703 | Method for treatment of external secretion disorders | Jul 12, 2000 | Issued |
| 09/612533 | Method of modulating expression of LDL-receptor-related protein and uses thereof | Jul 6, 2000 | Abandoned |
| 09/610538 | Methods fordecreasing pge2: PGF2a and zinc: cadmium ratios and for regulaing inhibiting the Concentration of zinc-containing and PGE2 - Dependent Matrix Metalloproteinases in the body of a mammal | Jul 6, 2000 | Abandoned |
| 09/610073 | Compositions and method for treatment of chronic inflammatory diseases | Jul 4, 2000 | Abandoned |
Array
(
[id] => 1475291
[patent_doc_number] => 06387959
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Antiviral therapy'
[patent_app_type] => B1
[patent_app_number] => 09/608716
[patent_app_country] => US
[patent_app_date] => 2000-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6353
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387959.pdf
[firstpage_image] =>[orig_patent_app_number] => 09608716
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/608716 | Antiviral therapy | Jun 29, 2000 | Issued |
| 09/605054 | Slow-release pharmaceutical formulations containing mizolastine | Jun 27, 2000 | Abandoned |
Array
(
[id] => 1281654
[patent_doc_number] => 06642219
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Progestogen-antiprogestogen regimens'
[patent_app_type] => B1
[patent_app_number] => 09/554429
[patent_app_country] => US
[patent_app_date] => 2000-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3351
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642219.pdf
[firstpage_image] =>[orig_patent_app_number] => 09554429
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/554429 | Progestogen-antiprogestogen regimens | Jun 25, 2000 | Issued |
| 09/582119 | COSMETIC OR PHARMACEUTICAL PREPARATIONS HAVING A REDUCED FEELING OF STICKINESS, COMPRISING GLYCEROL ESTERS OF ALPHA-HYDROXYCARBOXYLIC ACIDS AND SATURATED FATTY ACIDS | Jun 21, 2000 | Abandoned |
Array
(
[id] => 1279156
[patent_doc_number] => 06646013
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-11
[patent_title] => 'Nutrient formulations for disease reduction'
[patent_app_type] => B1
[patent_app_number] => 09/596036
[patent_app_country] => US
[patent_app_date] => 2000-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 12
[patent_no_of_words] => 34698
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/646/06646013.pdf
[firstpage_image] =>[orig_patent_app_number] => 09596036
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/596036 | Nutrient formulations for disease reduction | Jun 14, 2000 | Issued |
| 09/554994 | METHOD FOR TREATING ALZHEIMER'S DISEASE | May 22, 2000 | Abandoned |
Array
(
[id] => 7622249
[patent_doc_number] => 06977252
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-12-20
[patent_title] => 'Use of 1,4-benzothiazepine derivatives as drugs for overcoming resistance to anticancer drugs'
[patent_app_type] => utility
[patent_app_number] => 09/979231
[patent_app_country] => US
[patent_app_date] => 2000-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8433
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/977/06977252.pdf
[firstpage_image] =>[orig_patent_app_number] => 09979231
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/979231 | Use of 1,4-benzothiazepine derivatives as drugs for overcoming resistance to anticancer drugs | May 18, 2000 | Issued |
Array
(
[id] => 1316293
[patent_doc_number] => 06608065
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-19
[patent_title] => 'Use of cGMP phosphodiesterase inhibitors in methods to treat female sexual dysfunction'
[patent_app_type] => B1
[patent_app_number] => 09/573905
[patent_app_country] => US
[patent_app_date] => 2000-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4447
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/608/06608065.pdf
[firstpage_image] =>[orig_patent_app_number] => 09573905
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/573905 | Use of cGMP phosphodiesterase inhibitors in methods to treat female sexual dysfunction | May 17, 2000 | Issued |
| 09/572206 | Topical bisphosphonates for prevention of bone resorption | May 16, 2000 | Abandoned |
| 09/569486 | Combination therapy for the treatment of migraine | May 10, 2000 | Abandoned |
| 09/530781 | METHOD FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH APOPTOSIS USING N-HETEROCYLIC GLYOXYLAMIDE COMPOUNDS | May 4, 2000 | Abandoned |